Lack of Association Between PDCD-1 Polymorphisms and Colorectal Cancer Risk: A Case-Control Study

References

• Ai L, Xu A, Xu J. 2020. Roles of PD-1/PD-L1 pathway: signaling, cancer, and beyond. Adv Exp Med Biol. 1248:33–59.
   PubMed Web of Science ®Google Scholar
• Al-Zalabani A. 2020. Preventability of colorectal cancer in Saudi Arabia: fraction of cases attributable to modifiable risk factors in 2015–2040. Int J Environ Res Public Health. 17:320.
   PubMed Web of Science ®Google Scholar
• Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2017. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 66:683–91.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424.
   PubMed Web of Science ®Google Scholar
• Campos FG, Logullo Waitzberg AG, Kiss DR, Waitzberg DL, Habr-Gama A, Gama-Rodrigues J. 2005. Diet and colorectal cancer: current evidence for etiology and prevention. Nutr Hosp. 20:18–25.
   PubMedGoogle Scholar
• Chen J, Chen Z. 2014. The effect of immune microenvironment on the progression and prognosis of colorectal cancer. Med Oncol. 31:82.
   PubMed Web of Science ®Google Scholar
• Chen S, Qiu H, Liu C, Wang Y, Tang W, Kang M. 2018. Relationship between IGF2BP2 and IGFBP3 polymorphisms and susceptibility to non-small-cell lung cancer: a case-control study in Eastern Chinese Han population. Cancer Manag Res. 10:2965–75.
   PubMed Web of Science ®Google Scholar
• Chen JX, Yi XJ, Gao SX, Sun JX. 2020. The possible regulatory effect of the PD-1/PD-L1 signaling pathway on Tregs in ovarian cancer. Gen Physiol Biophys. 39:319–30.
   PubMed Web of Science ®Google Scholar
• Cho YA, Lee J, Oh JH, Chang HJ, Sohn DK, Shin A, Kim J. 2019. Genetic risk score, combined lifestyle factors and risk of colorectal cancer. Cancer Res Treat. 51:1033–40.
   PubMed Web of Science ®Google Scholar
• Dehaghani AS, Kashef MA, Ghaemenia M, Sarraf Z, Khaghanzadeh N, Fattahi MJ, Ghaderi A. 2009. PDCD1, CTLA-4 and p53 gene polymorphism and susceptibility to gestational trophoblastic diseases. J Reprod Med. 54:25–31.
   PubMed Web of Science ®Google Scholar
• Ding G, Wang Y, Chen Y, Yin J, Liu C, Fan Y, Qiu H, Tang W, Chen S. 2017. Methylenetetrahydrofolate reductase tagging polymorphisms are associated with risk of esophagogastric junction adenocarcinoma: a case-control study involving 2,740 Chinese Han subjects. Oncotarget. 8:111482–94.
   PubMedGoogle Scholar
• Dong W, Gong M, Shi Z, Xiao J, Zhang J, Peng J. 2016. Programmed cell death-1 polymorphisms decrease the cancer risk: a meta-analysis involving twelve case-control studies. PloS One. 11:e0152448.
   PubMed Web of Science ®Google Scholar
• Dong Y, Han Y, Huang Y, Jiang S, Huang Z, Chen R, Yu Z, Yu K, Zhang S. 2020. PD-L1 is expressed and promotes the expansion of regulatory T cells in acute myeloid leukemia. Front Immunol. 11:1710.
   PubMed Web of Science ®Google Scholar
• Dong Y, Zhou J, Zhu Y, Luo L, He T, Hu H, Liu H, Zhang Y, Luo D, Xu S, et, and Teng Z. 2017. Abdominal obesity and colorectal cancer risk: systematic review and meta-analysis of prospective studies. Biosci Rep. 37(6):BSR20170945.
   Web of Science ®Google Scholar
• Faruk M, Ibrahim S, Aminu SM, Adamu A, Abdullahi A, Suleiman AM, Rafindadi AH, Mohammed A, Iliyasu Y, Idoko J, et al. 2021. Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin. PloS One. 16:e0245581.
   PubMed Web of Science ®Google Scholar
• Ge J, Zhu L, Zhou J, Li G, Li Y, Li S, Wu Z, Rong J, Yuan H, Liu Y, et al. 2015. Association between co-inhibitory molecule gene tagging single nucleotide polymorphisms and the risk of colorectal cancer in Chinese. J Cancer Res Clin Oncol. 141:1533–44.
   PubMed Web of Science ®Google Scholar
• Gerber M. 2009. Background review paper on total fat, fatty acid intake and cancers. Ann Nutr Metab. 55:140–61.
   PubMed Web of Science ®Google Scholar
• Grasso CS, Giannakis M, Wells DK, Hamada T, Mu XJ, Quist M, Nowak JA, Nishihara R, Qian ZR, Inamura K, et al. 2018. Genetic mechanisms of immune evasion in colorectal cancer. Cancer Discov. 8:730–49.
   PubMed Web of Science ®Google Scholar
• Hua Z, Li D, Xiang G, Xu F, Jie G, Fu Z, Jie Z, Da P, Li D. 2011. PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China. Breast Cancer Res Treat. 129:195–201.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J Clin. 61:69–90.
   PubMed Web of Science ®Google Scholar
• Keir ME, Butte MJ, Freeman GJ, Sharpe AH. 2008. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 26:677–704.
   PubMed Web of Science ®Google Scholar
• Kumagai S, Togashi Y, Kamada T, Sugiyama E, Nishinakamura H, Takeuchi Y, Vitaly K, Itahashi K, Maeda Y, Matsui S, et al. 2020. The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies. Nat Immunol. 21:1346–58.
   PubMed Web of Science ®Google Scholar
• Kune GA, Vitetta L. 1992. Alcohol consumption and the etiology of colorectal cancer: a review of the scientific evidence from 1957 to 1991. Nutr Cancer. 18:97–111.
   PubMed Web of Science ®Google Scholar
• Lee MS, Menter DG, Kopetz S. 2017. RIght versus left colon cancer biology: integrating the consensus molecular subtypes. J Natl Compr Canc Netw. 15:411–19.
   PubMed Web of Science ®Google Scholar
• Li Z, Li N, Zhu Q, Zhang G, Han Q, Zhang P, Xun M, Wang Y, Zeng X, Yang C, et al. 2013. Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection. Infect Genet Evol. 14:240–46.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, He L, Shi Y. 2009. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.Bio-x.Cn). Cell Res. 19:519–23.
   PubMed Web of Science ®Google Scholar
• Liu J, Tang W, Lin W, Wang Y, Chen Y, Wang J, Liu M, Xu W, Lin J, Zhang L. 2019. Lack of association between CTLA-4 genetic polymorphisms and noncardiac gastric cancer in a Chinese population. DNA Cell Biol. 38:443–48.
   PubMed Web of Science ®Google Scholar
• Lund EK, Belshaw NJ, Elliott GO, Johnson IT. 2011. Recent advances in understanding the role of diet and obesity in the development of colorectal cancer. Proc Nutr Soc. 70:194–204.
   PubMed Web of Science ®Google Scholar
• Marisa L, Svrcek M, Collura A, Becht E, Cervera P, Wanherdrick K, Buhard O, Goloudina A, Jonchere V, Selves J, et al. 2018. The balance between cytotoxic T-cell lymphocytes and immune checkpoint expression in the prognosis of colon tumors. J Natl Cancer Inst. 110:68–77.
   Google Scholar
• Mojtahedi Z, Mohmedi M, Rahimifar S, Erfani N, Hosseini SV, Ghaderi A. 2012. Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with colon cancer. Gene. 508:229–32.
   PubMed Web of Science ®Google Scholar
• Nagai Y, Hata K, Kawai K, Murono K, Yasuda K, Otani K, Nishikawa T, Tanaka T, Kiyomatsu T, Nozawa H, et al. 2016. Clinicopathological features of colorectal cancer patients under the age of 50: recent experience and case-control study of prognosis in a Japanese cohort. Digestion. 93:272–79.
   PubMed Web of Science ®Google Scholar
• Nagle CM, Wilson LF, Hughes MC, Ibiebele TI, Miura K, Bain CJ, Whiteman DC, Webb PM. 2015. Cancers in Australia in 2010 attributable to inadequate consumption of fruit, non-starchy vegetables and dietary fibre. Aust N Z J Public Health. 39:422–28.
   PubMed Web of Science ®Google Scholar
• Oh SW, Kim YH, Choi YS, Chang DK, Son HJ, Rhee PL, Kim JJ, Rhee JC, Yun SH, Lee WY, et al. 2008. The comparison of the risk factors and clinical manifestations of proximal and distal colorectal cancer. Dis Colon Rectum. 51:56–61.
   PubMed Web of Science ®Google Scholar
• Peng QH, Wang CH, Chen HM, Zhang RX, Pan ZZ, Lu ZH, Wang GY, Yue X, Huang W, Liu RY. 2021. CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer. J Immunother Cancer. 9:e001638.
   PubMed Web of Science ®Google Scholar
• Qiu H, Wang Y, Kang M, Ding H, Liu C, Tang W, Xiao Z, Chen Y. 2017. The relationship between IGF2BP2 and PPARG polymorphisms and susceptibility to esophageal squamous-cell carcinomas in the eastern Chinese Han population. Onco Targets Ther. 10:5525–32.
   PubMed Web of Science ®Google Scholar
• Qiu H, Xie Z, Tang W, Liu C, Wang Y, Gu H, Zheng Q. 2021. Association between microRNA-146a, -499a and -196a-2 SNPs and non-small cell lung cancer: a case-control study involving 2249 subjects. Biosci Rep. 41(2):BSR20201158.
   Web of Science ®Google Scholar
• Qiu H, Zheng L, Tang W, Yin P, Cheng F, Wang L. 2014. Programmed death-1 (PD-1) polymorphisms in Chinese patients with esophageal cancer. Clin Biochem. 47:612–17.
   PubMed Web of Science ®Google Scholar
• Riley JL. 2009. PD-1 signaling in primary T cells. Immunol Rev. 229:114–25.
   PubMed Web of Science ®Google Scholar
• Savabkar S, Azimzadeh P, Chaleshi V, Nazemalhosseini Mojarad E, Aghdaei HA. 2013. Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with gastric cancer. Gastroenterol Hepatol Bed Bench. 6:178–82.
   PubMedGoogle Scholar
• Shi YY, He L. 2005. Shesis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15:97–98.
   PubMed Web of Science ®Google Scholar
• Shirakami Y, Ohnishi M, Sakai H, Tanaka T, Shimizu M. 2017. Prevention of colorectal cancer by targeting obesity-related disorders and inflammation. Int J Mol Sci. 18:908.
   PubMed Web of Science ®Google Scholar
• Siraj AK, Parvathareddy SK, Annaiyappanaidu P, Haqawi W, Al-Rasheed M, AlManea HM, AlHussaini HF, Al-Dayel F, Al-Kuraya KS. 2021. PD-L1 expression is associated with deficient mismatch repair and poor prognosis in middle eastern colorectal cancers. J Pers Med. 11:73.
   PubMed Web of Science ®Google Scholar
• Tang W, Chen S, Chen Y, Lin J, Lin J, Wang Y, Liu C, Kang M. 2017. Programmed death-1 polymorphisms is associated with risk of esophagogastric junction adenocarcinoma in the Chinese Han population: a case-control study involving 2,740 subjects. Oncotarget. 8:39198–208.
   PubMedGoogle Scholar
• Tang W, Chen Y, Chen S, Sun B, Gu H, Kang M. 2015. Programmed death-1 (PD-1) polymorphism is associated with gastric cardia adenocarcinoma. Int J Clin Exp Med. 8:8086–93.
   PubMed Web of Science ®Google Scholar
• Tang W, Chen S, Kang M, Liu J, Liu C. 2019. Investigation of BTLA tagging variants with risk of esophagogastric junction adenocarcinoma. Biosci Rep. 39(12):BSR20191770.
   Web of Science ®Google Scholar
• Tang W, Zhang S, Qiu H, Wang L, Sun B, Yin J, Gu H. 2014. Genetic variations in MTHFR and esophageal squamous cell carcinoma susceptibility in Chinese Han population. Med Oncol. 31:915.
   PubMed Web of Science ®Google Scholar
• Tiemersma EW, Kampman E, Bueno de Mesquita HB, Bunschoten A, van Schothorst EM, Kok FJ, Kromhout D. 2002. Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study. Cancer Causes Control: CCC. 13:383–93.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen S, Kang M, Tang W, Gu H, Yin J, Huang Z. 2015. Genetic variations in MTHFR and gastric cardia adenocarcinoma susceptibility in the Chinese Han population. Int J Clin Exp Med. 8:18936–44.
   PubMed Web of Science ®Google Scholar
• Wang L, Lo CH, He X, Hang D, Wang M, Wu K, Chan AT, Ogino S, Giovannucci EL, Song M. 2020. Risk factor profiles differ for cancers of different regions of the colorectum. Gastroenterology. 159:241–56 e213.
   PubMed Web of Science ®Google Scholar
• Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. 2005. Colorectal cancer. Lancet. 365:153–65.
   PubMed Web of Science ®Google Scholar
• Wielandt AM, Villarroel C, Hurtado C, Simian D, Zamorano D, Martinez M, Castro M, Vial MT, Kronberg U, Lopez-Kostner F. 2017. Characterization of patients with sporadic colorectal cancer following the new Consensus Molecular Subtypes (CMS). Rev Med Chil. 145:419–30.
   PubMed Web of Science ®Google Scholar
• Xu M, Chen YM, Huang J, Fang YJ, Huang WQ, Yan B, Lu MS, Pan ZZ, Zhang CX. 2016. Flavonoid intake from vegetables and fruits is inversely associated with colorectal cancer risk: a case-control study in China. Br J Nutr. 116:1275–87.
   PubMed Web of Science ®Google Scholar
• Yang J, Liu J, Chen Y, Tang W, Liu C, Sun Y, Chen J. 2019. Association of CTLA-4 tagging polymorphisms and haplotypes with hepatocellular carcinoma risk: a case-control study. Medicine. 98:e16266.
   PubMed Web of Science ®Google Scholar
• Zang B, Chen C, Zhao JQ. 2020. PD-1 gene rs10204525 and rs7421861 polymorphisms are associated with increased risk and clinical features of esophageal cancer in a Chinese Han population. Aging. 12:3771–90.
   PubMedGoogle Scholar
• Zhai Y, Zhao WH, Chen CM. 2010. Verification on the cut-offs of waist circumference for defining central obesity in Chinese elderly and tall adults. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi. 31:621–25.
   PubMedGoogle Scholar
• Zhang S, Chen S, Chen Y, Kang M, Liu C, Qiu H, Wang Y, Tang W. 2017. Investigation of methylenetetrahydrofolate reductase tagging polymorphisms with colorectal cancer in Chinese Han population. Oncotarget. 8:63518–27.
   PubMedGoogle Scholar
• Zhang S, Lin J, Jiang J, Chen Y, Tang W, Liu L. 2019. Association between methylenetetrahydrofolate reductase tagging polymorphisms and susceptibility of hepatocellular carcinoma: a case-control study. Biosci Rep. 39(11):BSR20192517.
   Web of Science ®Google Scholar
• Zhang X, Zhang S, Li Y, Detrano RC, Chen K, Li X, Zhao L, Benjamin EJ, Wu Y. 2009. Association of obesity and atrial fibrillation among middle-aged and elderly Chinese. Int J Obes. 33:1318–25.
   Web of Science ®Google Scholar
• Zhang J, Zhao T, Xu C, Huang J, Yu H. 2016. The association between polymorphisms in the PDCD1 gene and the risk of cancer: a PRISMA-compliant meta-analysis. Medicine. 95:e4423.
   PubMedGoogle Scholar
• Zhao Y, Mao Z, Pang H, Zhao X, Zhang S, Gao Z, Yang Y, Fang T, Ma Q, Ma X, et al. 2018. Association of programmed cell death 1 (PDCD1) gene polymorphisms with colorectal cancer among Han Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics. 35:219–23.
   PubMedGoogle Scholar
• Zhou RM, Li Y, Wang N, Huang X, Cao SR, Shan BE. 2016. Association of programmed death-1 polymorphisms with the risk and prognosis of esophageal squamous cell carcinoma. Cancer Genet. 209:365–75.
   PubMed Web of Science ®Google Scholar
• Zou C, Qiu H, Tang W, Wang Y, Lan B, Chen Y. 2018. CTLA4 tagging polymorphisms and risk of colorectal cancer: a case-control study involving 2,306 subjects. Onco Targets Ther. 11:4609–19.
   PubMed Web of Science ®Google Scholar